[1] |
Ge Fei, Zhu Hui, Cheng Kai, Lu Yu, Xu Jian.
Study on the determination of isoniazid and its metabolites concentration in plasma by high-performance liquid chromatography-mass spectrometry
[J]. Chinese Journal of Antituberculosis, 2024, 46(5): 549-556.
|
[2] |
Ren Ruyan, Xue Yi, Liang Qian, Huang Hairong.
The mechanisms identification of the susceptibility discrepancy to isoniazid among clinical isolates of Mycobacterium kansasii
[J]. Chinese Journal of Antituberculosis, 2023, 45(8): 728-733.
|
[3] |
TIAN Li, ZHOU Wei, HUANG Xing, WU Xian-wei, ZHANG Hui-yong, LU Zhen-hui, ZHANG Shao-yan.
Analysis of gene mutation characteristics of isoniazid-resistant Mycobacterium tuberculosis in China
[J]. Chinese Journal of Antituberculosis, 2022, 44(4): 354-361.
|
[4] |
Muradil·Mardan , Parhat·Yasin , Xu Tao, Cai Xiaoyu, Yakup·Abliz , Xun Chuanhui, Sheng Weibin, Mardan·Mamat .
Meta-analysis of operation combined with irrigation and drainage of focus lesion in the treatment of spinal tuberculosis
[J]. Chinese Journal of Antituberculosis, 2022, 44(12): 1314-1320.
|
[5] |
Chen Qifu, Zhang Shengkun, Liao Guangsheng, Tang Zhong, Zhan Shenlin, Deng Guofang, Zhang Peize, Chu Ming.
Clinical effect on the treatment of long tunnelled external ventricular drainage for tuberculous meningitis complicated with hydrocephalus
[J]. Chinese Journal of Antituberculosis, 2022, 44(11): 1187-1192.
|
[6] |
.
Guideline for clinical management of adverse reactions of bacillus Calmette-Guérin
[J]. Chinese Journal of Antituberculosis, 2021, 43(6): 532-538.
|
[7] |
WANG Yuan-zhi, LIANG Zheng-min, QU Meng-jin, ZHOU Xiang-mei.
Research progress of tuberculosis vaccine and vaccination strategy
[J]. Chinese Journal of Antituberculosis, 2021, 43(6): 625-630.
|
[8] |
SHU Wei, GE Qi-ping, HUANG Xue-rui, MA Li-ping, JI Bin-ying, CHEN Yu-hui, CHEN Xiao-you, JIANG Guang-lu, XIE Li, LI Bo, CHEN Sheng-yu, CHEN Sen-lin, YAN Jun-ping, SHI Lian, CHEN Ling, LI You-lun, XI Xiu-e, LIU Qian-ying, YAN Xing-lu, WANG Fei, WANG Fu-rong, WU Xiang, ZHANG Peng, LENG Xue-yan, CAO Wen-li, ZHANG Hai-qing, CUI Hong-zhe, YANG Cheng-qing, WU Chao, LI Juan, LI Hua, SUN Yu-xian, ZHANG Li-jie, XIE Shi-heng, NING Yu-jia, TIAN Xi-zhong, DU Jian, LI Liang, GAO Wei-wei.
Analysis of treatment outcomes of retreated pulmonary tuberculosis patients with isoniazid-resistance and rifampin-resistance
[J]. Chinese Journal of Antituberculosis, 2021, 43(4): 322-327.
|
[9] |
YANG Qing-luan, LIU Qi-hui, LIN Miao-yao, XU Yu-zhen, LIU Xue-feng, HE Zhang-yu-fan, HUANG Xi-tian, HAO Bin, SHAO Ling-yun, ZHANG Wen-hong, RUAN Qiao-ling.
A study of pharmacokinetic of rifapentine combined with isoniazid in the preventive treatment of tuberculosis in silicotic patients
[J]. Chinese Journal of Antituberculosis, 2021, 43(3): 228-232.
|
[10] |
WANG Xi-jiang, TAN Yun-hong, HE Wen-cong, OU Xi-chao, LIU Dong-xin, ZHAO Yan-lin.
The correlation between rifampicin and isoniazid resistance-related gene mutations and resistance level in Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2021, 43(3): 248-254.
|
[11] |
YUAN Yuan, MA Jia-ye, LIU Xu-hui, XIA Lu, LIU Ping, JIA Xiao-long, LU Shui-hua.
Pharmacokinetics and safety of high-dose isoniazid and rifapentine in healthy han population: A bio-equivalence trial
[J]. Chinese Journal of Antituberculosis, 2021, 43(12): 1314-1321.
|
[12] |
Beijing Chest Hospital,Capital Medical University,Editorial Board of Chinese Journal of Antituberculosis .
Expert consensus on polymorphism detection of N-acetyltransferase-2 encoding gene and appropriate isoniazid dosing for tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2021, 43(11): 1107-1112.
|
[13] |
ZHAO Ai-hua, KANG Wan-li, WANG Guo-zhi, GAO Zheng-lun, DU Wei-xin, LU Jin-biao, SHEN Xiao-bing, SU Cheng, XU Miao, ZHENG Su-hua.
Screening for latent tuberculosis infection and identification of BCG vaccination by recombinant Mycobacterium tuberculosis 11 kDa
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 821-825.
|
[14] |
CHEN Ning, SUN Lin, SHEN A-dong, HE Qiu-shui.
Possible causes of infection after BCG vaccination
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 869-873.
|
[15] |
ZHAO Jiao-jie,FU Lei,WANG Bin,ZHANG Lei,HU Ming-hao,LU Yu.
Establishment and application of pharmacodynamics and pharmacokinetics model in vitro
[J]. Chinese Journal of Antituberculosis, 2020, 42(4): 372-379.
|